Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 1/2 2Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 200Lymphoma 199Lymphoma, Non-Hodgkin 167Leukemia, Lymphocytic, Chronic, B-Cell 166Lymphoma, Large B-Cell, Diffuse 163Precursor Cell Lymphoblastic Leukemia-Lymphoma 154Leukemia 89Hodgkin Disease 89Lymphoma, Mantle-Cell 80Lymphoma, B-Cell, Marginal Zone 66Burkitt Lymphoma 65Leukemia, Myeloid, Acute 55Multiple Myeloma 52Lymphoma, Large-Cell, Immunoblastic 48Recurrence 44Neoplasms 38Myelodysplastic Syndromes 38Lymphoma, T-Cell, Cutaneous 36Mycosis Fungoides 30Lymphoma, Large-Cell, Anaplastic 30Waldenstrom Macroglobulinemia 28Leukemia, Myeloid, Chronic-Phase 28Myeloproliferative Disorders 27Lymphoma, B-Cell 27Leukemia, Myeloid, Accelerated Phase 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26Sezary Syndrome 25Leukemia, Biphenotypic, Acute 25Blast Crisis 24Primary Myelofibrosis 22

Interventions

Voriconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Immunologic Deficiency Syndromes × Lymphoid × Clear all
NCT00015665 2008-03-04

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
40 enrolled
Lymphoid

Immunologic Deficiency Syndromes, Infections, Lymphoma, Follicular, Mycoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡